ENG/中
老虎證券
市场
行情
24/7新闻
产品
Cash Boost账户
期权
A股通
港股
固定票息票据
美股
ETF
基金超市
美国国债
新加坡股
期货
Tiger BOSS Debit Card
老虎钱袋子
功能
经纪人
定投
CPF/SRS 投资
专栏
美股碎股
TigerAI
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
机构
Tiger Fund Management
机构服务
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
老虎API平台
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
和黃醫藥
14.96
+0.0700
0.47%
成交量:
3.99萬
成交額:
59.51萬
市值:
26.10億
市盈率:
5.65
高:
15.08
開:
14.84
低:
14.71
收:
14.89
52周最高:
19.50
52周最低:
11.51
股本:
1.74億
流通股本:
1.04億
量比:
1.05
換手率:
0.04%
股息:
- -
股息率:
- -
每股收益(TTM):
2.65
每股收益(LYR):
0.2000
淨資產收益率:
46.90%
總資產收益率:
-0.81%
市淨率:
2.12
市盈率(LYR):
74.80
資料載入中...
總覽
公司
新聞資訊
公告
和黃醫藥(00013.HK)擬3月5日舉行董事會會議批准年度業績
中金财经
·
02/06
零缺陷!和黃醫藥上海旗艦生產基地獲美國食藥管理部門認證
上观新闻
·
01/28
【券商聚焦】交銀國際維持和黃醫藥(00013)買入評級 指產品銷售即將重新步入增長通道
金吾财讯
·
01/26
更好滿足患者需求!浦東創新藥企持續發力
市场资讯
·
01/17
和黃醫藥漲逾5% SACHI III期研究結果於《柳葉刀》發表
智通财经
·
01/16
Black Titan Corp盤中異動 早盤股價大漲6.06%
市场透视
·
01/16
和黃醫藥盤中異動 早盤急速拉升5.23%報16.11美元
市场透视
·
01/16
港股異動 | 和黃醫藥(00013)再升逾4% 月內累漲逾兩成 SACHI III期研究結果於《柳葉刀》發表
智通财经
·
01/16
和黃醫藥盤中升逾3% SACHI III期研究結果於《柳葉刀》發表
新浪港股
·
01/15
百時美施貴寶宣佈評估瑪伐凱泰治療青少年有症狀的梗阻性肥厚型心肌病(oHCM)的III 期臨牀試驗SCOUT-HCM取得陽性結果
美通社
·
01/14
和黃醫藥(00013)宣佈SACHI III期研究結果於《柳葉刀 (The Lancet)》發表
智通财经
·
01/14
多重利好刺激股價走出「五連陽」,「躲過牛市」的和黃醫藥(00013)迎來反轉時刻?
智通财经
·
01/09
和黃醫藥盤中異動 早盤快速拉升5.02%
市场透视
·
01/07
索樂匹尼布取得突破性進展!和黃醫藥股價漲5.45%
港股解码
·
01/07
和黃醫藥(00013)宣佈索樂匹尼布用於治療温抗體型自身免疫性溶血性貧血的 ESLIM-02中國研究的III期階段取得陽性頂線結果
智通财经
·
01/07
和黃醫藥(00013)啓動現正進行中的索凡替尼聯合卡瑞利珠單抗用於治療初治胰腺導管腺癌研究的III期階段
智通财经
·
01/05
和黃醫藥(00013)宣佈賽沃替尼 (savolitinib) 用於治療伴有MET擴增的胃癌患者的中國新藥上市申請獲受理並獲納入優先審評
智通财经
·
2025/12/30
和黃醫藥(00013)宣佈凡瑞格拉替尼 (HMPL-453) 用於二線治療肝內膽管癌的中國新藥上市申請獲受理並獲納入優先審評
智通财经
·
2025/12/29
國家藥監局批准阿夫凱泰片上市
新京报
·
2025/12/22
賽諾菲:第二代心肌肌球蛋白抑制劑星舒平在華獲批 實現「全球首發」
中国网财经
·
2025/12/17
更多
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/HCM/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"HCM","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HCM\",,,,,undefined,":{"symbol":"HCM","market":"US","secType":"STK","nameCN":"和黃醫藥","latestPrice":14.96,"timestamp":1770757200000,"preClose":14.89,"halted":0,"volume":39910,"delay":0,"changeRate":0.004701141705842867,"floatShares":104000000,"shares":174433934,"eps":2.649215,"marketStatus":"盤前交易","change":0.07,"latestTime":"02-11 09:15:14 EST","open":14.84,"high":15.08,"low":14.71,"amount":595143.06839,"amplitude":0.024849,"askPrice":16.11,"askSize":220,"bidPrice":12,"bidSize":43,"shortable":3,"etf":0,"ttmEps":2.649215,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1770820200000},"marketStatusCode":1,"adr":1,"adrRate":5,"listingDate":1458187200000,"exchange":"NASDAQ","adjPreClose":14.96,"postHourTrading":{"tag":"盘后","latestPrice":14.96,"preClose":14.96,"latestTime":"17:09 EST","volume":174,"amount":2541.64,"timestamp":1770761369949,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.0465287000951113,"impliedVol":0.4058,"impliedVolPercentile":0.544},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"HCM\",,,,,undefined,":{"symbol":"HCM","floatShares":104000000,"roa":"-0.81%","roe":"46.90%","lyrEps":0.199995,"volumeRatio":1.0465287000951113,"shares":174433934,"dividePrice":0,"high":15.08,"amplitude":0.024849,"preClose":14.89,"low":14.71,"week52Low":11.505,"pbRate":"2.12","psRate":"4.33","week52High":19.5,"institutionHeld":0,"latestPrice":14.96,"committee":-0.673004,"eps":2.649215,"divideRate":0,"volume":39910,"delay":0,"ttmEps":2.649215,"open":14.84,"prevYearClose":13.33,"prevWeekClose":15.18,"prevMonthClose":15,"prevQuarterClose":13.33,"fiveDayClose":14.39,"twentyDayClose":14.93,"sixtyDayClose":15.28,"earningDate":1772640000000,"earningTime":"盘前"},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/HCM\",params:#limit:5,,,undefined,":[{"date":"2026-03-05","symbol":"HCM","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/12","expectedEps":null,"defaultRemindTime":1772701200000,"name":null,"time":"盤前","dateTimestamp":1772686800000,"actualEps":null},{"market":"US","date":"2025-08-07","symbol":"HCM","fiscalQuarterEnding":"2025/06","expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"pre","actualEps":null},{"market":"US","date":"2025-03-19","symbol":"HCM","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"盤前","type":"earning","dateTimestamp":1742356800000,"reportTimeType":"pre","actualEps":null},{"date":"2024-07-31","symbol":"HCM","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2024/06","expectedEps":null,"defaultRemindTime":1722412800000,"name":null,"time":"盤前","dateTimestamp":1722398400000,"actualEps":null},{"date":"2024-02-28","symbol":"HCM","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2023/12","expectedEps":null,"defaultRemindTime":1709110800000,"name":null,"time":"盤前","dateTimestamp":1709096400000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"HCM\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"HCM\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.4167,"buy":0.3333,"hold":0.1667,"sell":0.0833,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":12,"updateTime":1758430800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/HCM\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"HCM","date":"2026-02-10","current":5.646956,"percent":0.788571,"low":-115.327022,"twenty":-64.328552,"median":-12.821268,"eighty":5.577919,"high":86.489551,"avg":-21.199199,"sd":43.991205,"marketCap":2572947932.59},"quantilePoints":[{"date":"2021-02-12","current":-46.336944,"twenty":-91.457833,"median":-41.932627,"eighty":-27.778854,"marketCap":5113235514.24},{"date":"2021-02-19","current":-44.811155,"twenty":-90.65071,"median":-41.932627,"eighty":-27.778854,"marketCap":4944866178.29},{"date":"2021-02-26","current":-38.841579,"twenty":-89.766106,"median":-41.816439,"eighty":-27.778854,"marketCap":4286129378.92},{"date":"2021-03-05","current":-33.870975,"twenty":-89.003074,"median":-41.41365,"eighty":-27.776445,"marketCap":4258597777.62},{"date":"2021-03-12","current":-32.350855,"twenty":-88.635912,"median":-41.151481,"eighty":-27.776445,"marketCap":4067472920.26},{"date":"2021-03-19","current":-33.249369,"twenty":-87.307229,"median":-40.874511,"eighty":-27.776445,"marketCap":4180443207.02},{"date":"2021-03-26","current":-30.982552,"twenty":-86.768103,"median":-40.703264,"eighty":-27.778854,"marketCap":3895436248.03},{"date":"2021-04-01","current":-32.26063,"twenty":-86.192609,"median":-40.508564,"eighty":-27.778854,"marketCap":4056129016.55},{"date":"2021-04-09","current":-33.137949,"twenty":-84.984122,"median":-40.185037,"eighty":-27.776445,"marketCap":4166434318.18},{"date":"2021-04-16","current":-34.129797,"twenty":-84.235269,"median":-40.070583,"eighty":-27.776445,"marketCap":4291139241.78},{"date":"2021-04-23","current":-34.843079,"twenty":-84.024169,"median":-40.002655,"eighty":-27.776445,"marketCap":4380820320.94},{"date":"2021-04-30","current":-34.438006,"twenty":-83.830644,"median":-39.797322,"eighty":-27.776445,"marketCap":4329890574.8},{"date":"2021-05-07","current":-31.821317,"twenty":-83.830644,"median":-39.648909,"eighty":-27.776445,"marketCap":4000894157.31},{"date":"2021-05-14","current":-30.312709,"twenty":-83.490922,"median":-39.473341,"eighty":-27.776445,"marketCap":3811216913.73},{"date":"2021-05-21","current":-32.458918,"twenty":-83.490922,"median":-39.204978,"eighty":-27.776445,"marketCap":4081059812.14},{"date":"2021-05-28","current":-34.354172,"twenty":-83.387891,"median":-38.87818,"eighty":-27.776445,"marketCap":4319349995.04},{"date":"2021-06-04","current":-35.068157,"twenty":-82.646756,"median":-38.63441,"eighty":-27.776445,"marketCap":4409119282.86},{"date":"2021-06-11","current":-35.414599,"twenty":-81.346061,"median":-38.54063,"eighty":-27.776445,"marketCap":4452677569.33},{"date":"2021-06-18","current":-34.032624,"twenty":-77.803409,"median":-38.350657,"eighty":-27.776445,"marketCap":4278921905.79},{"date":"2021-06-25","current":-35.828259,"twenty":-76.471988,"median":-38.192608,"eighty":-27.732156,"marketCap":5400465105.51},{"date":"2021-07-02","current":-43.838432,"twenty":-74.83281,"median":-38.175147,"eighty":-27.732156,"marketCap":6607854466.82},{"date":"2021-07-09","current":-41.097094,"twenty":-74.120934,"median":-38.175147,"eighty":-27.732156,"marketCap":6194647318.34},{"date":"2021-07-16","current":-44.549309,"twenty":-72.365744,"median":-38.175147,"eighty":-27.732156,"marketCap":6715006390.46},{"date":"2021-07-23","current":-45.310589,"twenty":-70.91277,"median":-38.175147,"eighty":-27.732156,"marketCap":6829755650.02},{"date":"2021-07-30","current":-39.696122,"twenty":-69.643297,"median":-38.175147,"eighty":-27.732156,"marketCap":7083098072.62},{"date":"2021-08-06","current":-40.119386,"twenty":-69.529012,"median":-38.24796,"eighty":-27.870771,"marketCap":7158622428.55},{"date":"2021-08-13","current":-39.097534,"twenty":-69.529012,"median":-38.459009,"eighty":-28.149056,"marketCap":6976290399.57},{"date":"2021-08-20","current":-36.065012,"twenty":-69.529012,"median":-38.476067,"eighty":-28.245756,"marketCap":6435188201.17},{"date":"2021-08-27","current":-35.744125,"twenty":-69.529012,"median":-38.476067,"eighty":-28.472218,"marketCap":6377931431.79},{"date":"2021-09-03","current":-40.719987,"twenty":-69.529012,"median":-38.500254,"eighty":-28.576552,"marketCap":7265789374.3},{"date":"2021-09-10","current":-37.614485,"twenty":-69.529012,"median":-38.500254,"eighty":-28.654578,"marketCap":6711665355.27},{"date":"2021-09-17","current":-36.698865,"twenty":-69.529012,"median":-38.500254,"eighty":-28.733157,"marketCap":6548288680.59},{"date":"2021-09-24","current":-35.293788,"twenty":-69.529012,"median":-38.500254,"eighty":-29.073592,"marketCap":6297576451.05},{"date":"2021-10-01","current":-34.394618,"twenty":-69.529012,"median":-38.500254,"eighty":-29.166917,"marketCap":6137134715.17},{"date":"2021-10-08","current":-32.006355,"twenty":-69.529012,"median":-38.500254,"eighty":-29.281853,"marketCap":5710989951.59},{"date":"2021-10-15","current":-30.941818,"twenty":-69.529012,"median":-38.500254,"eighty":-29.322519,"marketCap":5521041305.66},{"date":"2021-10-22","current":-31.083316,"twenty":-69.529012,"median":-38.500254,"eighty":-29.56411,"marketCap":5546289439.2},{"date":"2021-10-29","current":-28.737101,"twenty":-69.529012,"median":-38.500254,"eighty":-29.623518,"marketCap":5127647054.8},{"date":"2021-11-05","current":-29.069569,"twenty":-69.529012,"median":-38.500254,"eighty":-29.71681,"marketCap":5186970395.65},{"date":"2021-11-12","current":-29.581373,"twenty":-69.529012,"median":-38.500254,"eighty":-29.71681,"marketCap":5278293116.21},{"date":"2021-11-19","current":-29.210209,"twenty":-69.529012,"median":-38.500254,"eighty":-29.770213,"marketCap":5212065210.66},{"date":"2021-11-26","current":-34.003345,"twenty":-69.529012,"median":-38.500254,"eighty":-29.883033,"marketCap":6067318798.77},{"date":"2021-12-03","current":-32.23822,"twenty":-69.529012,"median":-38.500254,"eighty":-29.920748,"marketCap":5752362415.71},{"date":"2021-12-10","current":-32.455639,"twenty":-69.529012,"median":-38.500254,"eighty":-29.981314,"marketCap":5791157109.58},{"date":"2021-12-17","current":-33.631509,"twenty":-69.529012,"median":-38.500254,"eighty":-30.078029,"marketCap":6000971032.9},{"date":"2021-12-23","current":-34.093269,"twenty":-69.529012,"median":-38.500254,"eighty":-30.131346,"marketCap":6083364180.02},{"date":"2021-12-31","current":-34.446938,"twenty":-69.529012,"median":-38.500254,"eighty":-30.191644,"marketCap":6146470612.85},{"date":"2022-01-07","current":-32.437839,"twenty":-69.499738,"median":-38.495738,"eighty":-30.248303,"marketCap":5787980958.33},{"date":"2022-01-14","current":-30.159284,"twenty":-69.499738,"median":-38.495738,"eighty":-30.30988,"marketCap":5381411525.89},{"date":"2022-01-21","current":-28.701706,"twenty":-69.499738,"median":-38.495738,"eighty":-30.30988,"marketCap":5121331366.35},{"date":"2022-01-28","current":-25.003785,"twenty":-69.499738,"median":-38.495738,"eighty":-30.30988,"marketCap":4461500388},{"date":"2022-02-04","current":-26.206511,"twenty":-69.499738,"median":-38.495738,"eighty":-30.30988,"marketCap":4676106460.92},{"date":"2022-02-11","current":-25.261882,"twenty":-69.499738,"median":-38.495738,"eighty":-30.30988,"marketCap":4507553408.67},{"date":"2022-02-18","current":-25.371388,"twenty":-69.499738,"median":-38.495738,"eighty":-30.30988,"marketCap":4527092765.71},{"date":"2022-02-25","current":-25.683001,"twenty":-69.499738,"median":-38.495738,"eighty":-30.30988,"marketCap":4582694996.65},{"date":"2022-03-04","current":-18.605078,"twenty":-69.499738,"median":-38.495738,"eighty":-30.30988,"marketCap":3621441412.39},{"date":"2022-03-11","current":-15.051903,"twenty":-69.499738,"median":-38.495738,"eighty":-30.30988,"marketCap":2929822790.96},{"date":"2022-03-18","current":-17.884701,"twenty":-69.499738,"median":-38.495738,"eighty":-30.30988,"marketCap":3481221099.72},{"date":"2022-03-25","current":-16.435173,"twenty":-69.499738,"median":-38.495738,"eighty":-30.30988,"marketCap":3199073429.96},{"date":"2022-04-01","current":-17.213787,"twenty":-69.499738,"median":-38.495738,"eighty":-30.296587,"marketCap":3350629340.45},{"date":"2022-04-08","current":-16.063966,"twenty":-69.499738,"median":-38.495738,"eighty":-30.248303,"marketCap":3126818936.54},{"date":"2022-04-14","current":-15.298862,"twenty":-69.499738,"median":-38.495738,"eighty":-30.248303,"marketCap":2977892925.34},{"date":"2022-04-22","current":-14.712002,"twenty":-69.499738,"median":-38.495738,"eighty":-30.248303,"marketCap":2863661789.31},{"date":"2022-04-29","current":-13.558507,"twenty":-69.499738,"median":-38.495738,"eighty":-30.233334,"marketCap":2639136325.07},{"date":"2022-05-06","current":-9.781934,"twenty":-69.499738,"median":-38.495738,"eighty":-30.233334,"marketCap":1904033919.87},{"date":"2022-05-13","current":-9.355898,"twenty":-69.499738,"median":-38.495738,"eighty":-30.233334,"marketCap":1821106717.16},{"date":"2022-05-20","current":-8.719868,"twenty":-69.499738,"median":-38.495738,"eighty":-30.192872,"marketCap":1697304784.04},{"date":"2022-05-27","current":-8.314191,"twenty":-69.499738,"median":-38.495738,"eighty":-30.132008,"marketCap":1618340539.42},{"date":"2022-06-03","current":-8.628685,"twenty":-69.499738,"median":-38.495738,"eighty":-30.014085,"marketCap":1679556410.8},{"date":"2022-06-10","current":-9.214019,"twenty":-69.499738,"median":-38.495738,"eighty":-29.921757,"marketCap":1793490418.23},{"date":"2022-06-17","current":-9.914833,"twenty":-69.499738,"median":-38.495738,"eighty":-29.772739,"marketCap":1929902622.2},{"date":"2022-06-24","current":-11.463874,"twenty":-69.529012,"median":-38.500254,"eighty":-29.620948,"marketCap":2231420118.48},{"date":"2022-07-01","current":-11.684606,"twenty":-69.529012,"median":-38.500254,"eighty":-29.322519,"marketCap":2274385364.21},{"date":"2022-07-08","current":-13.343207,"twenty":-69.529012,"median":-38.500254,"eighty":-29.287087,"marketCap":2597228702.6},{"date":"2022-07-15","current":-11.176596,"twenty":-69.529012,"median":-38.500254,"eighty":-29.224911,"marketCap":2175501973.98},{"date":"2022-07-22","current":-11.270185,"twenty":-69.529012,"median":-38.500254,"eighty":-29.070663,"marketCap":2193719071.38},{"date":"2022-07-29","current":-11.175537,"twenty":-69.529012,"median":-38.500254,"eighty":-28.942893,"marketCap":2175295964.08},{"date":"2022-08-05","current":-8.775775,"twenty":-69.251314,"median":-38.382485,"eighty":-28.654578,"marketCap":2238805741.78},{"date":"2022-08-12","current":-9.033436,"twenty":-68.891568,"median":-38.244645,"eighty":-28.437317,"marketCap":2304538127.97},{"date":"2022-08-19","current":-8.567373,"twenty":-68.544113,"median":-38.122097,"eighty":-28.189312,"marketCap":2185639465.6},{"date":"2022-08-26","current":-8.387311,"twenty":-68.170644,"median":-38.040806,"eighty":-28.005292,"marketCap":2139703595.07},{"date":"2022-09-02","current":-8.548157,"twenty":-67.834739,"median":-37.799605,"eighty":-27.755834,"marketCap":2180737445.02},{"date":"2022-09-09","current":-9.050042,"twenty":-67.711165,"median":-37.635536,"eighty":-27.581671,"marketCap":2308774223.62},{"date":"2022-09-16","current":-7.943729,"twenty":-67.568141,"median":-37.567583,"eighty":-27.025151,"marketCap":2026540548.26},{"date":"2022-09-23","current":-5.590294,"twenty":-67.181713,"median":-37.492528,"eighty":-26.772818,"marketCap":1426151024.94},{"date":"2022-09-30","current":-6.0166,"twenty":-66.839726,"median":-37.322153,"eighty":-26.671597,"marketCap":1534906655.67},{"date":"2022-10-07","current":-5.591973,"twenty":-66.311726,"median":-37.125983,"eighty":-26.346066,"marketCap":1426579346.77},{"date":"2022-10-14","current":-5.380359,"twenty":-65.731379,"median":-36.974767,"eighty":-26.200139,"marketCap":1372594209.76},{"date":"2022-10-21","current":-5.717908,"twenty":-65.287627,"median":-36.817162,"eighty":-25.987978,"marketCap":1458706953.83},{"date":"2022-10-28","current":-5.527847,"twenty":-64.824798,"median":-36.677678,"eighty":-25.683533,"marketCap":1410220116.58},{"date":"2022-11-04","current":-5.851883,"twenty":-64.330928,"median":-36.605148,"eighty":-25.425489,"marketCap":1492885555.67},{"date":"2022-11-11","current":-6.401199,"twenty":-64.014025,"median":-36.490673,"eighty":-25.004374,"marketCap":1633022846.35},{"date":"2022-11-18","current":-7.274108,"twenty":-63.706519,"median":-36.322732,"eighty":-24.409241,"marketCap":1855712187.21},{"date":"2022-11-25","current":-7.207228,"twenty":-63.464069,"median":-36.186955,"eighty":-24.11915,"marketCap":1838650480.47},{"date":"2022-12-02","current":-9.190517,"twenty":-63.185779,"median":-36.105478,"eighty":-23.638994,"marketCap":2344610998.55},{"date":"2022-12-09","current":-9.61663,"twenty":-63.052013,"median":-35.941799,"eighty":-23.186635,"marketCap":2453317745.69},{"date":"2022-12-16","current":-9.580976,"twenty":-62.885553,"median":-35.895711,"eighty":-22.098398,"marketCap":2444222152.95},{"date":"2022-12-23","current":-9.787361,"twenty":-62.624453,"median":-35.77363,"eighty":-19.25547,"marketCap":2496873279.39},{"date":"2022-12-30","current":-10.536978,"twenty":-62.385355,"median":-35.672655,"eighty":-17.975781,"marketCap":2688109439.12},{"date":"2023-01-06","current":-11.292055,"twenty":-62.385355,"median":-35.672655,"eighty":-17.975781,"marketCap":2880738826.05},{"date":"2023-01-13","current":-12.006871,"twenty":-62.385355,"median":-35.672655,"eighty":-17.975781,"marketCap":3063096916},{"date":"2023-01-20","current":-11.709152,"twenty":-62.385355,"median":-35.672655,"eighty":-17.975781,"marketCap":2987145347.84},{"date":"2023-01-27","current":-13.678274,"twenty":-62.385355,"median":-35.672655,"eighty":-17.975781,"marketCap":3489492038.73},{"date":"2023-02-03","current":-13.421402,"twenty":-62.385355,"median":-35.672655,"eighty":-17.975781,"marketCap":3423960784.69},{"date":"2023-02-10","current":-11.253893,"twenty":-62.385355,"median":-35.672655,"eighty":-17.975781,"marketCap":2871003089.59},{"date":"2023-02-17","current":-11.126783,"twenty":-62.385355,"median":-35.672655,"eighty":-17.975781,"marketCap":2838575719.48},{"date":"2023-02-24","current":-10.526624,"twenty":-62.385355,"median":-35.672655,"eighty":-17.975781,"marketCap":2685468087.11},{"date":"2023-03-03","current":-8.178091,"twenty":-62.385355,"median":-35.672655,"eighty":-17.975781,"marketCap":2950941580.83},{"date":"2023-03-10","current":-7.048231,"twenty":-62.385355,"median":-35.672655,"eighty":-17.975781,"marketCap":2543248476.73},{"date":"2023-03-17","current":-6.898847,"twenty":-62.129617,"median":-35.521426,"eighty":-17.494664,"marketCap":2489345563.09},{"date":"2023-03-24","current":-6.686154,"twenty":-61.887252,"median":-35.353445,"eighty":-16.993619,"marketCap":2412598207.8},{"date":"2023-03-31","current":-6.37509,"twenty":-61.656831,"median":-35.262393,"eighty":-16.360932,"marketCap":2300355689.58},{"date":"2023-04-06","current":-6.683867,"twenty":-61.173417,"median":-35.179989,"eighty":-15.530351,"marketCap":2411773158.27},{"date":"2023-04-14","current":-8.330975,"twenty":-60.579404,"median":-34.997612,"eighty":-15.233985,"marketCap":3006107420.26},{"date":"2023-04-21","current":-7.844979,"twenty":-58.935582,"median":-34.87491,"eighty":-14.298511,"marketCap":2830742978.45},{"date":"2023-04-28","current":-7.371003,"twenty":-58.19167,"median":-34.698276,"eighty":-13.498182,"marketCap":2659716150.51},{"date":"2023-05-05","current":-7.738249,"twenty":-57.886927,"median":-34.494942,"eighty":-13.330799,"marketCap":2792231115.94},{"date":"2023-05-10","current":-6.689752,"twenty":-57.031699,"median":-34.449204,"eighty":-13.235907,"marketCap":2413896528.97},{"date":"2023-05-19","current":-5.998961,"twenty":-55.865984,"median":-34.307805,"eighty":-12.635355,"marketCap":2164635282.58},{"date":"2023-05-26","current":-6.159383,"twenty":-54.610824,"median":-34.25037,"eighty":-12.304624,"marketCap":2222520838.42},{"date":"2023-06-02","current":-5.896649,"twenty":-53.769073,"median":-34.189583,"eighty":-12.145184,"marketCap":2127717267.98},{"date":"2023-06-09","current":-5.61732,"twenty":-51.214539,"median":-34.098254,"eighty":-11.978924,"marketCap":2026925451.44},{"date":"2023-06-16","current":-6.556151,"twenty":-49.534985,"median":-33.981992,"eighty":-11.716113,"marketCap":2365688683.03},{"date":"2023-06-23","current":-5.188019,"twenty":-48.575977,"median":-33.870975,"eighty":-11.579838,"marketCap":1872018712.18},{"date":"2023-06-30","current":-5.593173,"twenty":-48.355361,"median":-33.644023,"eighty":-11.480192,"marketCap":2018212544.46},{"date":"2023-07-07","current":-5.74663,"twenty":-48.060411,"median":-33.395098,"eighty":-11.347014,"marketCap":2073585481.13},{"date":"2023-07-14","current":-6.162744,"twenty":-47.529274,"median":-33.182708,"eighty":-11.253893,"marketCap":2223733732.38},{"date":"2023-07-21","current":-6.029127,"twenty":-47.271291,"median":-33.060515,"eighty":-11.126783,"marketCap":2175519941.92},{"date":"2023-07-28","current":-6.932729,"twenty":-46.699003,"median":-32.915735,"eighty":-11.040035,"marketCap":2501571410.93},{"date":"2023-08-04","current":-93.761454,"twenty":-46.694862,"median":-32.915511,"eighty":-11.022195,"marketCap":2758743281.53},{"date":"2023-08-11","current":-81.599272,"twenty":-46.694862,"median":-32.915511,"eighty":-11.022195,"marketCap":2400895380.31},{"date":"2023-08-18","current":-77.476828,"twenty":-46.694862,"median":-32.915511,"eighty":-11.022195,"marketCap":2279600704.92},{"date":"2023-08-25","current":-81.532031,"twenty":-46.694862,"median":-32.915511,"eighty":-11.022195,"marketCap":2398916965.04},{"date":"2023-09-01","current":-91.16165,"twenty":-46.694862,"median":-32.915511,"eighty":-11.022195,"marketCap":2682249230.75},{"date":"2023-09-08","current":-82.080837,"twenty":-46.694862,"median":-32.915511,"eighty":-11.022195,"marketCap":2415064449.43},{"date":"2023-09-15","current":-91.04279,"twenty":-46.694862,"median":-32.915511,"eighty":-11.022195,"marketCap":2678752002.43},{"date":"2023-09-22","current":-92.694372,"twenty":-46.694862,"median":-32.915511,"eighty":-11.022195,"marketCap":2727346501.33},{"date":"2023-09-29","current":-98.479468,"twenty":-46.694862,"median":-32.915511,"eighty":-11.022195,"marketCap":2897561388.24},{"date":"2023-10-06","current":-95.557789,"twenty":-46.694862,"median":-32.915511,"eighty":-11.022195,"marketCap":2811596806.75},{"date":"2023-10-13","current":-104.104604,"twenty":-46.694862,"median":-32.915511,"eighty":-11.022195,"marketCap":3063069736.6},{"date":"2023-10-20","current":-97.193204,"twenty":-46.694862,"median":-32.915511,"eighty":-11.022195,"marketCap":2859715641.7},{"date":"2023-10-27","current":-106.376978,"twenty":-46.530742,"median":-32.902446,"eighty":-10.996202,"marketCap":3129929817.79},{"date":"2023-11-03","current":-113.333081,"twenty":-46.530742,"median":-32.902446,"eighty":-10.996202,"marketCap":3334599265.81},{"date":"2023-11-10","current":-110.227088,"twenty":-46.530742,"median":-32.902446,"eighty":-10.996202,"marketCap":3243211592.97},{"date":"2023-11-17","current":-106.765557,"twenty":-46.530742,"median":-32.902446,"eighty":-10.996202,"marketCap":3141362969.86},{"date":"2023-11-24","current":-109.005881,"twenty":-46.530742,"median":-32.902446,"eighty":-10.996202,"marketCap":3207280038.84},{"date":"2023-12-01","current":-106.403892,"twenty":-46.530742,"median":-32.902446,"eighty":-10.996202,"marketCap":3130721682.86},{"date":"2023-12-08","current":-107.396023,"twenty":-46.570339,"median":-32.902622,"eighty":-11.004866,"marketCap":3159913178.84},{"date":"2023-12-15","current":-114.044196,"twenty":-46.570339,"median":-32.902622,"eighty":-11.004866,"marketCap":3355522389.76},{"date":"2023-12-22","current":-102.844083,"twenty":-46.570339,"median":-32.902622,"eighty":-11.004866,"marketCap":3025981471.63},{"date":"2023-12-29","current":-104.57108,"twenty":-46.530742,"median":-32.902446,"eighty":-10.996202,"marketCap":3076794889.66},{"date":"2024-01-05","current":-97.230433,"twenty":-46.534985,"median":-32.902271,"eighty":-10.987537,"marketCap":2860811039.44},{"date":"2024-01-12","current":-93.788775,"twenty":-46.679291,"median":-32.902271,"eighty":-10.987537,"marketCap":2759547110.77},{"date":"2024-01-19","current":-81.700747,"twenty":-46.617006,"median":-32.897915,"eighty":-10.978873,"marketCap":2403881098.3},{"date":"2024-01-26","current":-75.326321,"twenty":-46.679291,"median":-32.902271,"eighty":-10.987537,"marketCap":2216326338.51},{"date":"2024-02-02","current":-71.131016,"twenty":-46.679291,"median":-32.902271,"eighty":-10.987537,"marketCap":2092887876.59},{"date":"2024-02-09","current":-81.199004,"twenty":-46.679291,"median":-32.902271,"eighty":-10.987537,"marketCap":2389118297.6},{"date":"2024-02-16","current":-84.08213,"twenty":-46.679291,"median":-32.902271,"eighty":-10.987537,"marketCap":2473948515.34},{"date":"2024-02-23","current":-90.549714,"twenty":-46.679291,"median":-32.902271,"eighty":-10.987537,"marketCap":2664244213.15},{"date":"2024-03-01","current":25.78938,"twenty":-46.577409,"median":-32.890218,"eighty":-10.953678,"marketCap":2599053804.56},{"date":"2024-03-08","current":25.462774,"twenty":-45.923863,"median":-32.835083,"eighty":-10.669452,"marketCap":2566138402.88},{"date":"2024-03-15","current":30.565906,"twenty":-45.475099,"median":-32.781518,"eighty":-10.516791,"marketCap":3080431970.72},{"date":"2024-03-22","current":28.107757,"twenty":-45.159274,"median":-32.614784,"eighty":-10.173858,"marketCap":2832699783.36},{"date":"2024-03-28","current":28.634683,"twenty":-44.696755,"median":-32.47029,"eighty":-9.952238,"marketCap":2885803386.55},{"date":"2024-04-05","current":27.994802,"twenty":-44.286361,"median":-32.437839,"eighty":-9.676235,"marketCap":2821316061},{"date":"2024-04-12","current":30.73697,"twenty":-43.790515,"median":-32.383262,"eighty":-9.438819,"marketCap":3097671829.52},{"date":"2024-04-19","current":28.50518,"twenty":-43.289592,"median":-32.314387,"eighty":-9.308641,"marketCap":2872752027.27},{"date":"2024-04-26","current":30.691652,"twenty":-43.110703,"median":-32.225561,"eighty":-9.195832,"marketCap":3093104761.67},{"date":"2024-05-03","current":32.810779,"twenty":-42.925086,"median":-32.090068,"eighty":-9.093044,"marketCap":3306670223.29},{"date":"2024-05-10","current":37.311124,"twenty":-42.754864,"median":-32.013835,"eighty":-9.030734,"marketCap":3760215012.95},{"date":"2024-05-17","current":34.774349,"twenty":-42.519618,"median":-31.926574,"eighty":-8.918389,"marketCap":3504558884.2},{"date":"2024-05-24","current":31.870114,"twenty":-42.406308,"median":-31.731124,"eighty":-8.759961,"marketCap":3211870090.63},{"date":"2024-05-31","current":31.840964,"twenty":-42.321902,"median":-31.616611,"eighty":-8.700526,"marketCap":3208932296.09},{"date":"2024-06-07","current":30.649626,"twenty":-42.069616,"median":-31.52512,"eighty":-8.629123,"marketCap":3088869266.47},{"date":"2024-06-14","current":31.662211,"twenty":-41.839089,"median":-31.349545,"eighty":-8.522865,"marketCap":3190917592.65},{"date":"2024-06-21","current":30.278072,"twenty":-41.728492,"median":-31.238878,"eighty":-8.390524,"marketCap":3051424142.17},{"date":"2024-06-28","current":29.565199,"twenty":-41.372482,"median":-31.203757,"eighty":-8.378139,"marketCap":2979580713.93},{"date":"2024-07-05","current":31.469656,"twenty":-41.171139,"median":-31.162778,"eighty":-8.350361,"marketCap":3171511930.81},{"date":"2024-07-12","current":32.497273,"twenty":-40.923634,"median":-31.106867,"eighty":-8.304192,"marketCap":3275075163.39},{"date":"2024-07-15","current":32.449018,"twenty":-40.883856,"median":-31.083316,"eighty":-8.295844,"marketCap":3270211975.59},{"date":"2024-08-02","current":-73.252444,"twenty":-40.734722,"median":-31.035175,"eighty":-8.234512,"marketCap":3074405105.35},{"date":"2024-08-09","current":-80.817949,"twenty":-40.867508,"median":-31.065396,"eighty":-8.234512,"marketCap":3391929340.66},{"date":"2024-08-16","current":-75.419733,"twenty":-41.029282,"median":-31.08164,"eighty":-8.234512,"marketCap":3165366196.73},{"date":"2024-08-23","current":-70.090937,"twenty":-41.233818,"median":-31.11816,"eighty":-8.234512,"marketCap":2941716616.05},{"date":"2024-08-30","current":-70.200291,"twenty":-41.56077,"median":-31.11816,"eighty":-8.234512,"marketCap":2946306212.08},{"date":"2024-09-06","current":-70.181618,"twenty":-41.811937,"median":-31.11816,"eighty":-8.234512,"marketCap":2945522520.42},{"date":"2024-09-13","current":-69.744859,"twenty":-41.964487,"median":-31.11816,"eighty":-8.234512,"marketCap":2927191709.7},{"date":"2024-09-20","current":-71.615538,"twenty":-42.245335,"median":-31.11816,"eighty":-8.234512,"marketCap":3005704154.39},{"date":"2024-09-27","current":-77.826204,"twenty":-42.356867,"median":-31.178512,"eighty":-8.234512,"marketCap":3266365753.33},{"date":"2024-10-04","current":-82.757332,"twenty":-42.493301,"median":-31.289313,"eighty":-8.234512,"marketCap":3473325219.61},{"date":"2024-10-11","current":-77.57877,"twenty":-42.605,"median":-31.548561,"eighty":-8.234512,"marketCap":3255980971.33},{"date":"2024-10-18","current":-82.642206,"twenty":-42.921343,"median":-31.761378,"eighty":-8.234512,"marketCap":3468493340.62},{"date":"2024-10-25","current":-85.256412,"twenty":-43.016758,"median":-32.001326,"eighty":-8.234512,"marketCap":3578211606.32},{"date":"2024-10-31","current":-74.954799,"twenty":-43.239177,"median":-32.06209,"eighty":-8.234512,"marketCap":3145852920.58},{"date":"2024-11-08","current":-72.692272,"twenty":-43.62805,"median":-32.188654,"eighty":-8.233187,"marketCap":3050894659.02},{"date":"2024-11-15","current":-68.34495,"twenty":-44.002855,"median":-32.188654,"eighty":-8.233187,"marketCap":2868437537.19},{"date":"2024-11-22","current":-71.356956,"twenty":-44.564262,"median":-32.188654,"eighty":-8.233187,"marketCap":2994851469.12},{"date":"2024-11-29","current":-69.444249,"twenty":-44.793919,"median":-32.188654,"eighty":-8.233187,"marketCap":2914575122.66},{"date":"2024-12-06","current":-72.472893,"twenty":-45.245557,"median":-32.188654,"eighty":-8.233187,"marketCap":3041687288.89},{"date":"2024-12-13","current":-63.887587,"twenty":-45.737028,"median":-32.188654,"eighty":-8.233187,"marketCap":2681361994.64},{"date":"2024-12-20","current":-60.618869,"twenty":-46.397964,"median":-32.188654,"eighty":-8.233187,"marketCap":2544173945.26},{"date":"2024-12-27","current":-59.140915,"twenty":-46.839034,"median":-32.188654,"eighty":-8.233187,"marketCap":2482144206.05},{"date":"2025-01-03","current":-61.983512,"twenty":-58.665008,"median":-32.188654,"eighty":-8.233187,"marketCap":2601448012.27},{"date":"2025-01-10","current":-62.344458,"twenty":-60.772335,"median":-32.162743,"eighty":-8.231863,"marketCap":2616596879.5},{"date":"2025-01-17","current":-58.299182,"twenty":-60.956229,"median":-32.162743,"eighty":-8.231863,"marketCap":2446816652.19},{"date":"2025-01-24","current":-55.029289,"twenty":-60.956229,"median":-32.162743,"eighty":-8.231863,"marketCap":2309579252.99},{"date":"2025-01-31","current":-55.715915,"twenty":-60.956229,"median":-32.162743,"eighty":-8.231863,"marketCap":2338396949.9},{"date":"2025-02-07","current":-53.467713,"twenty":-60.956229,"median":-32.162743,"eighty":-8.231863,"marketCap":2244039918.87},{"date":"2025-02-14","current":-55.662649,"twenty":-60.956229,"median":-32.162743,"eighty":-8.231863,"marketCap":2336161367.94},{"date":"2025-02-21","current":-65.870772,"twenty":-61.683916,"median":-32.162743,"eighty":-8.231863,"marketCap":2764596287.73},{"date":"2025-02-28","current":-68.37646,"twenty":-62.164703,"median":-32.162743,"eighty":-8.231863,"marketCap":2869760015.65},{"date":"2025-03-07","current":-68.073966,"twenty":-63.73881,"median":-32.212901,"eighty":-8.230538,"marketCap":2857064342.6},{"date":"2025-03-14","current":-64.060444,"twenty":-64.03835,"median":-32.350855,"eighty":-8.230538,"marketCap":2688616845.96},{"date":"2025-03-21","current":66.690257,"twenty":-64.27493,"median":-32.387163,"eighty":-8.133641,"marketCap":2516156700.16},{"date":"2025-03-28","current":69.598373,"twenty":-64.27493,"median":-32.387163,"eighty":-8.03762,"marketCap":2625877056.17},{"date":"2025-04-04","current":66.45471,"twenty":-64.27493,"median":-32.387163,"eighty":-7.971128,"marketCap":2507269769.7},{"date":"2025-04-11","current":62.287088,"twenty":-64.221309,"median":-32.385213,"eighty":-7.932321,"marketCap":2350029524.92},{"date":"2025-04-17","current":63.677927,"twenty":-64.221309,"median":-32.385213,"eighty":-7.856958,"marketCap":2402504520.39},{"date":"2025-04-25","current":68.867703,"twenty":-64.27493,"median":-32.387163,"eighty":-7.463009,"marketCap":2598309537.11},{"date":"2025-05-02","current":70.00808,"twenty":-64.27493,"median":-32.387163,"eighty":-7.279097,"marketCap":2641334825.25},{"date":"2025-05-09","current":68.704213,"twenty":-64.27493,"median":-32.387163,"eighty":-7.149579,"marketCap":2592141250.63},{"date":"2025-05-16","current":61.687385,"twenty":-64.27493,"median":-32.387163,"eighty":-7.043509,"marketCap":2327403358.61},{"date":"2025-05-23","current":63.281782,"twenty":-64.27493,"median":-32.387163,"eighty":-6.961701,"marketCap":2387558359.74},{"date":"2025-05-30","current":63.269782,"twenty":-64.27493,"median":-32.387163,"eighty":-6.905623,"marketCap":2387105606.22},{"date":"2025-06-06","current":69.305193,"twenty":-64.27493,"median":-32.387163,"eighty":-6.731447,"marketCap":2614815642.59},{"date":"2025-06-13","current":77.57647,"twenty":-64.27493,"median":-32.387163,"eighty":-6.684324,"marketCap":2926882637.05},{"date":"2025-06-20","current":66.613989,"twenty":-64.328552,"median":-32.388787,"eighty":-6.628323,"marketCap":2513279187.31},{"date":"2025-06-27","current":68.13786,"twenty":-64.328552,"median":-32.388787,"eighty":-6.512219,"marketCap":2570773291.5},{"date":"2025-07-03","current":71.210096,"twenty":-64.328552,"median":-32.332621,"eighty":-6.42721,"marketCap":2686685730.87},{"date":"2025-07-11","current":72.572229,"twenty":-64.328552,"median":-32.162743,"eighty":-6.348415,"marketCap":2738077620.44},{"date":"2025-07-18","current":78.450021,"twenty":-64.328552,"median":-32.034774,"eighty":-6.196909,"marketCap":2959840870.68},{"date":"2025-07-25","current":79.176352,"twenty":-64.328552,"median":-31.872185,"eighty":-6.09053,"marketCap":2987244578.9},{"date":"2025-08-01","current":79.150274,"twenty":-64.328552,"median":-31.228469,"eighty":-6.029127,"marketCap":2986260682.88},{"date":"2025-08-08","current":5.542888,"twenty":-64.328552,"median":-31.16064,"eighty":-5.997559,"marketCap":2587874674.36},{"date":"2025-08-15","current":6.05636,"twenty":-64.328552,"median":-31.08164,"eighty":-5.942503,"marketCap":2827605584.52},{"date":"2025-08-22","current":5.906994,"twenty":-64.328552,"median":-30.975476,"eighty":-5.89292,"marketCap":2757868947.74},{"date":"2025-08-29","current":5.520039,"twenty":-64.328552,"median":-30.692254,"eighty":-5.837513,"marketCap":2577207033.23},{"date":"2025-09-05","current":5.773462,"twenty":-64.348416,"median":-30.330097,"eighty":-5.808798,"marketCap":2695525455.08},{"date":"2025-09-12","current":6.495449,"twenty":-64.328552,"median":-30.080885,"eighty":-5.771921,"marketCap":3032608180.86},{"date":"2025-09-19","current":6.361988,"twenty":-64.328552,"median":-29.783366,"eighty":-5.714542,"marketCap":2970297324.15},{"date":"2025-09-26","current":5.650636,"twenty":-64.328552,"median":-29.518985,"eighty":-5.625246,"marketCap":2638180258.96},{"date":"2025-10-03","current":5.974641,"twenty":-64.328552,"median":-29.153616,"eighty":-5.593173,"marketCap":2789452419.21},{"date":"2025-10-10","current":5.77709,"twenty":-64.328552,"median":-28.940995,"eighty":-5.517888,"marketCap":2697219539.83},{"date":"2025-10-17","current":5.438003,"twenty":-64.328552,"median":-27.613233,"eighty":-5.358513,"marketCap":2538905465.8},{"date":"2025-10-24","current":5.566179,"twenty":-64.328552,"median":-26.616683,"eighty":-5.24792,"marketCap":2598748900.26},{"date":"2025-10-31","current":5.323193,"twenty":-64.328552,"median":-26.259383,"eighty":5.316035,"marketCap":2485303049.86},{"date":"2025-11-07","current":5.692673,"twenty":-64.328552,"median":-25.831006,"eighty":5.422523,"marketCap":2657806660.11},{"date":"2025-11-14","current":5.538607,"twenty":-64.328552,"median":-25.574426,"eighty":5.520039,"marketCap":2585875851.6},{"date":"2025-11-21","current":5.228746,"twenty":-64.328552,"median":-25.210285,"eighty":5.538607,"marketCap":2441207293.13},{"date":"2025-11-28","current":5.415727,"twenty":-64.328552,"median":-23.125526,"eighty":5.538607,"marketCap":2528505283.04},{"date":"2025-12-05","current":5.234536,"twenty":-64.328552,"median":-17.960601,"eighty":5.538607,"marketCap":2443910845.71},{"date":"2025-12-12","current":5.038573,"twenty":-64.328552,"median":-17.484256,"eighty":5.538607,"marketCap":2352418929.73},{"date":"2025-12-19","current":4.906191,"twenty":-64.328552,"median":-16.980776,"eighty":5.538607,"marketCap":2290612111.23},{"date":"2025-12-26","current":4.891268,"twenty":-64.328552,"median":-16.438933,"eighty":5.538607,"marketCap":2283644877.95},{"date":"2026-01-02","current":5.059143,"twenty":-64.328552,"median":-15.7025,"eighty":5.538607,"marketCap":2362022580.17},{"date":"2026-01-09","current":5.365899,"twenty":-64.328552,"median":-15.255817,"eighty":5.538607,"marketCap":2505241950.3},{"date":"2026-01-16","current":5.891548,"twenty":-64.328552,"median":-14.764247,"eighty":5.547002,"marketCap":2750658052.81},{"date":"2026-01-23","current":5.589246,"twenty":-64.328552,"median":-13.552429,"eighty":5.564767,"marketCap":2609518309.27},{"date":"2026-01-30","current":5.579629,"twenty":-64.328552,"median":-13.378369,"eighty":5.577919,"marketCap":2605028588.75},{"date":"2026-02-06","current":5.333987,"twenty":-64.328552,"median":-13.08706,"eighty":5.577919,"marketCap":2490342690.22},{"date":"2026-02-10","current":5.510917,"twenty":-64.328552,"median":-12.821268,"eighty":5.577919,"marketCap":2572947932.59}],"updateTime":1770819314900},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"HCM\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2609805566","title":"和黃醫藥(00013.HK)擬3月5日舉行董事會會議批准年度業績","url":"https://stock-news.laohu8.com/highlight/detail?id=2609805566","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609805566?lang=zh_tw&edition=fundamental","pubTime":"2026-02-06 17:07","pubTimestamp":1770368825,"startTime":"0","endTime":"0","summary":"格隆汇2月6日丨和黄医药(00013.HK)宣布,公司将于2026年3月5日(星期四)举行董事会会议,以(其中包括)批准公司及其附属公司截至2025年12月31日止年度的年度业绩,并将其于同日下午7时正(香港时间)发布。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260206/32003916.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["00013","HCM","BK4588","BK1191","BK4007","BK4531","BK4585","BK1587","BK1588"],"gpt_icon":0},{"id":"2606619407","title":"零缺陷!和黃醫藥上海旗艦生產基地獲美國食藥管理部門認證","url":"https://stock-news.laohu8.com/highlight/detail?id=2606619407","media":"上观新闻","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606619407?lang=zh_tw&edition=fundamental","pubTime":"2026-01-28 13:03","pubTimestamp":1769576632,"startTime":"0","endTime":"0","summary":"日前,上海市战略性新兴产业重大项目——和黄医药上海旗舰生产基地,以零缺陷顺利通过美国食品药品监督管理局(FDA)现场检查。继2023年和黄医药苏州工厂以零缺陷通过FDA批准前检查,推动自主研发的呋喹替尼于美国成功上市,并于2025年再次通过监督检查后,此次上海旗舰生产基地成功通关,已是和黄医药第三次以零缺陷通过FDA现场检查。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202601283633431187.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4531","BK1191","BK1587","BK4585","BK1588","00013","BK4007","HCM","BK4588"],"gpt_icon":0},{"id":"2606622142","title":"【券商聚焦】交銀國際維持和黃醫藥(00013)買入評級 指產品銷售即將重新步入增長通道","url":"https://stock-news.laohu8.com/highlight/detail?id=2606622142","media":"金吾财讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606622142?lang=zh_tw&edition=fundamental","pubTime":"2026-01-26 09:43","pubTimestamp":1769391803,"startTime":"0","endTime":"0","summary":"该机构认为SAFFRON全球III期研究的成功概率较大。公司预计年中读出数据并提交NDA、2027年有望获批,该机构预计赛沃替尼全球销售峰值或超18亿美元。HMPL-A251已完成首个全球I期研究的首例患者给药,该机构建议重点关注其BD出海潜力。另两款ATTC候选分子将分别于1H26和2H26进入临床。","market":"sh","thumbnail":"https://static.szfiu.com/news/20250106/ZGNkM2E3NDVjMTk0N2Q5ZDk4NjYxNjc1YjA4NjMzOTA5MjkwMDE=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20250106/ZGNkM2E3NDVjMTk0N2Q5ZDk4NjYxNjc1YjA4NjMzOTA5MjkwMDE=.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1973906","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HCM","00013"],"gpt_icon":0},{"id":"2604679944","title":"更好滿足患者需求!浦東創新藥企持續發力","url":"https://stock-news.laohu8.com/highlight/detail?id=2604679944","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604679944?lang=zh_tw&edition=fundamental","pubTime":"2026-01-17 00:00","pubTimestamp":1768579200,"startTime":"0","endTime":"0","summary":"eslim-01研究旨在评估索乐匹尼布长期治疗成人慢性原发itp患者的疗效和安全性。共有16例患者接受了imc002单次输注治疗,并全部纳入安全性分析。其中15例患者可评估疗效。据悉,基于本次研究结果,易慕峰生物已启动imc002在晚期gc/gej患者中的iii期随机对照临床研究,以进一步验证疗效和安全性。此次数据发布标志着易慕峰生物在实体瘤car-t领域,尤其是胃癌等高未满足临床需求适应症上的持续推进,为晚期胃/gej癌患者提供了新的治疗希望。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260117004708a723b9e3&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260117004708a723b9e3&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCM","BK4585","BK4588","00013","BK4007","BK4531"],"gpt_icon":0},{"id":"2604446209","title":"和黃醫藥漲逾5% SACHI III期研究結果於《柳葉刀》發表","url":"https://stock-news.laohu8.com/highlight/detail?id=2604446209","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604446209?lang=zh_tw&edition=fundamental","pubTime":"2026-01-16 23:17","pubTimestamp":1768576666,"startTime":"0","endTime":"0","summary":"周五,和黄医药涨逾5%,报16.12美元。消息面上,和黄医药宣布,SACHI III期研究的结果于《柳叶刀》发表。SACHI是一项赛沃替尼和奥希替尼的联合疗法,用于治疗伴有MET扩增的接受一线表皮生长因子受体酪氨酸激酶抑制剂治疗后疾病进展的EGFR突变阳性局部晚期或转移性非小细胞肺癌患者的III期研究。基于SACHI研究的数据,赛沃替尼和奥希替尼的联合疗法已于2025年6月在中国获批。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116232631a72389bb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116232631a72389bb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCM","III","BK4007","BK4531","BK4134","BK4585","BK4588"],"gpt_icon":0},{"id":"2603992281","title":"Black Titan Corp盤中異動 早盤股價大漲6.06%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603992281","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603992281?lang=zh_tw&edition=fundamental","pubTime":"2026-01-16 22:56","pubTimestamp":1768575383,"startTime":"0","endTime":"0","summary":"北京时间2026年01月16日22时56分,Black Titan Corp股票出现异动,股价急速上涨6.06%。截至发稿,该股报1.75美元/股,成交量1.5502万股,换手率0.17%,振幅3.42%。Black Titan Corp股票所在的软件服务行业中,整体跌幅为0.41%。Black Titan Corp公司简介:Black Titan Corp 使用 PeopleSoft 平台提供人力资源和薪资咨询、软件实施和培训解决方案。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116225623a72374d6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260116225623a72374d6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4196","HCM","BK4585","BK4182","BTTC","BK4588","BK4134","BK4129","BK4007","BK4531"],"gpt_icon":0},{"id":"2604944627","title":"和黃醫藥盤中異動 早盤急速拉升5.23%報16.11美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2604944627","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2604944627?lang=zh_tw&edition=fundamental","pubTime":"2026-01-16 22:39","pubTimestamp":1768574365,"startTime":"0","endTime":"0","summary":"北京时间2026年01月16日22时39分,和黄医药股票出现异动,股价快速拉升5.23%。截至发稿,该股报16.11美元/股,成交量1.8325万股,换手率0.01%,振幅1.14%。和黄医药股票所在的制药行业中,整体跌幅为0.15%。该公司目前在全球范围内拥有多个临床研究的癌症候选药物组合,并在其中国本土市场拥有广泛的商业基础设施。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011622392597a22348&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026011622392597a22348&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["HCM","BK4585","BK4531","BK4007","BK4588"],"gpt_icon":0},{"id":"2603554869","title":"港股異動 | 和黃醫藥(00013)再升逾4% 月內累漲逾兩成 SACHI III期研究結果於《柳葉刀》發表","url":"https://stock-news.laohu8.com/highlight/detail?id=2603554869","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603554869?lang=zh_tw&edition=fundamental","pubTime":"2026-01-16 11:03","pubTimestamp":1768532615,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,和黄医药再涨超4%,月内累计涨幅超20%。消息面上,和黄医药宣布,SACHI III期研究的结果于《柳叶刀》发表。SACHI是一项赛沃替尼和奥希替尼的联合疗法,用于治疗伴有MET扩增的接受一线表皮生长因子受体酪氨酸激酶抑制剂治疗后疾病进展的EGFR突变阳性局部晚期或转移性非小细胞肺癌患者的III期研究。基于SACHI研究的数据,赛沃替尼和奥希替尼的联合疗法已于2025年6月在中国获批。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1393697.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HCM","BK1587","BK4531","BK4588","BK4585","BK1191","BK4134","BK1588","III","00013","BK4007"],"gpt_icon":0},{"id":"2603662471","title":"和黃醫藥盤中升逾3% SACHI III期研究結果於《柳葉刀》發表","url":"https://stock-news.laohu8.com/highlight/detail?id=2603662471","media":"新浪港股","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603662471?lang=zh_tw&edition=fundamental","pubTime":"2026-01-15 10:40","pubTimestamp":1768444800,"startTime":"0","endTime":"0","summary":" 和黄医药盘中涨超3%,截至发稿,股价上涨2.39%,现报23.98港元,成交额7741.10万港元。 据和黄医药官微消息,1月14日,和黄医药宣布SACHI III期研究的结果于《柳叶刀 》发表。 据介绍,赛沃替尼是一种强效、高选择性的口服MET TKI,由阿斯利康与和黄医药共同开发,并由阿斯利康商业化。基于SACHI研究的数据,赛沃替尼和奥希替尼的联合疗法已于2025年6月在中国获批。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/marketalerts/2026-01-15/doc-inhhiyxt4368442.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK1588","00013","HCM","III","BK4007","BK4531","BK4134","BK4585","BK1587","BK4588","BK1191"],"gpt_icon":0},{"id":"2603253613","title":"百時美施貴寶宣佈評估瑪伐凱泰治療青少年有症狀的梗阻性肥厚型心肌病(oHCM)的III 期臨牀試驗SCOUT-HCM取得陽性結果","url":"https://stock-news.laohu8.com/highlight/detail?id=2603253613","media":"美通社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603253613?lang=zh_tw&edition=fundamental","pubTime":"2026-01-14 19:55","pubTimestamp":1768391700,"startTime":"0","endTime":"0","summary":"SCOUT-HCM 的阳性研究结果展现了玛伐凯泰有望成为首个用于青少年 oHCM 患者的心肌肌球蛋白抑制剂。青少年oHCM严重损害健康,主要临床表现与运动耐量下降相关。在欧盟,玛伐凯泰获批用于治疗有症状的NYHA心功能分级II-III级的梗阻性肥厚型心肌病成人患者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://wwwold.prnasia.com/story/archive/4863243_ZH63243_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"prnasia","symbols":["LU1868836591.USD","LU0225771236.USD","LU1718418525.SGD","LU2242646821.SGD","LU0306807586.USD","LU1670710588.SGD","LU1670711123.USD","IE0002141913.USD","BK4134","IE00B2B36J28.USD","LU2125154935.USD","LU0114720955.EUR","LU1868837300.USD","LU1261432733.SGD","BK4585","LU0267386448.USD","IE00BJJMRZ35.SGD","IE00BFXG1179.USD","IE00BSNM7G36.USD","LU0225284248.USD","IE0009355771.USD","LU0061475181.USD","LU0456855351.SGD","IE00BJT1NW94.SGD","LU0306806265.USD","III","LU1430594728.SGD","BK4534","BK4559","LU1074936037.SGD","LU0321505868.SGD","LU1323610961.USD","LU1868836914.USD","LU1670710661.SGD","LU2242652126.USD","LU0237698245.USD","LU0321505439.SGD","LU1291159041.SGD","LU1868837136.USD","LU0096364046.USD","BMY","BK4588","LU0985481810.HKD","LU1571399168.USD","LU1989771016.USD","LU1093756168.USD","LU1585245621.USD","LU1093756325.SGD","LU0868494617.USD","HCM"],"gpt_icon":0},{"id":"2603666888","title":"和黃醫藥(00013)宣佈SACHI III期研究結果於《柳葉刀 (The Lancet)》發表","url":"https://stock-news.laohu8.com/highlight/detail?id=2603666888","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2603666888?lang=zh_tw&edition=fundamental","pubTime":"2026-01-14 12:11","pubTimestamp":1768363890,"startTime":"0","endTime":"0","summary":"智通财经APP讯,和黄医药 发布公告,公司今日宣布SACHI III期研究的结果于《柳叶刀 》发表。SACHI是一项赛沃替尼和奥希替尼的联合疗法用于治疗伴有MET扩增的接受一线表皮生长因子受体酪氨酸激酶抑制剂治疗后疾病进展的EGFR突变阳性局部晚期或转移性非小细胞肺癌患者的III期研究。基于SACHI研究的数据,赛沃替尼和奥希替尼的联合疗法已于2025年6月在中国获批。中国医学科学院肿瘤医院的王洁教授亦为SACHI 研究的联合主要研究者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1392627.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4588","HCM","00013","BK1587","III","BK4585","BK4531","BK1588","BK4007","BK1191","BK4134"],"gpt_icon":0},{"id":"2602207113","title":"多重利好刺激股價走出「五連陽」,「躲過牛市」的和黃醫藥(00013)迎來反轉時刻?","url":"https://stock-news.laohu8.com/highlight/detail?id=2602207113","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2602207113?lang=zh_tw&edition=fundamental","pubTime":"2026-01-09 19:41","pubTimestamp":1767958896,"startTime":"0","endTime":"0","summary":"相较之下,作为一家手握3款商业化创新药并拥有首创抗体靶向偶联药物的创新药企,和黄医药却最终以8.56%的年度跌幅收场,显著跑输指数。去年8月7日美股盘前,和黄医药公布了其2025年中报业绩。最新数据显示,和黄医药的港股通持股比例已达27.28%。这便是和黄医药在25H2期内股价最大回撤幅度高达35.12%的重要原因之一。根据此前II期研究结果,索乐匹尼布针对wAIHA的整体应答率为66.7%,并展现出良好的安全性特征。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1391129.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1588","00013","BK1587","HCM","BK4585","BK4588","BK1191","BK4531","BK4007"],"gpt_icon":0},{"id":"2601480429","title":"和黃醫藥盤中異動 早盤快速拉升5.02%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601480429","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601480429?lang=zh_tw&edition=fundamental","pubTime":"2026-01-07 22:46","pubTimestamp":1767797189,"startTime":"0","endTime":"0","summary":"北京时间2026年01月07日22时46分,和黄医药股票出现异动,股价急速上涨5.02%。截至发稿,该股报14.44美元/股,成交量7672股,换手率0.00%,振幅1.64%。和黄医药股票所在的制药行业中,整体涨幅为2.39%。和黄医药公司简介:和黄医药(中国)有限公司是一家生物制药公司,致力于发现、开发和商业化用于治疗癌症和免疫疾病的靶向疗法和免疫疗法。该公司目前在全球范围内拥有多个临床研究的癌症候选药物组合,并在其中国本土市场拥有广泛的商业基础设施。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010722462997a13368&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026010722462997a13368&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4531","HCM","BK4585","BK4588"],"gpt_icon":0},{"id":"2601291804","title":"索樂匹尼布取得突破性進展!和黃醫藥股價漲5.45%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601291804","media":"港股解码","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601291804?lang=zh_tw&edition=fundamental","pubTime":"2026-01-07 20:04","pubTimestamp":1767787448,"startTime":"0","endTime":"0","summary":"另值得关注的是,除了温抗体型自身免疫性溶血性贫血以外,索乐匹尼布治疗免疫性血小板减少症的研究亦正在进行中。和黄医药透露,公司计划于2026年上半年重新提交索乐匹尼布,用于二线治疗免疫性血小板减少症的新药上市申请。综合来看,索乐匹尼布具有不错的商业化前景,后续若其在温抗体型自身免疫性溶血性贫血、免疫性血小板减少症两大适应症的新药上市申请获成功,将有望为公司业绩增长贡献助力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107200638a6fead82&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107200638a6fead82&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4531","HCM","BK4585","BK4588","00013","BK4007"],"gpt_icon":0},{"id":"2601878841","title":"和黃醫藥(00013)宣佈索樂匹尼布用於治療温抗體型自身免疫性溶血性貧血的 ESLIM-02中國研究的III期階段取得陽性頂線結果","url":"https://stock-news.laohu8.com/highlight/detail?id=2601878841","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601878841?lang=zh_tw&edition=fundamental","pubTime":"2026-01-07 08:03","pubTimestamp":1767744211,"startTime":"0","endTime":"0","summary":"智通财经APP讯,和黄医药 公布,新型脾酪氨酸激酶抑制剂索乐匹尼布用于治疗温抗体型自身免疫性溶血性贫血成人患者的ESLIM-02研究的III期注册阶段已达到第5至 24周治疗期间持久血红蛋白应答这一主要终点。ESLIM-02研究的完整数据将提交于近期的学术会议上发表。和黄医药计划于2026年上半年向中国国家药品监督管理局提交索乐匹尼布用于治疗温抗体型自身免疫性溶血性贫血的新药上市申请。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1389595.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1588","BK4531","BK4588","HCM","BK4585","BK4134","III","00013","BK1191","BK4007","BK1587"],"gpt_icon":0},{"id":"2601078362","title":"和黃醫藥(00013)啓動現正進行中的索凡替尼聯合卡瑞利珠單抗用於治療初治胰腺導管腺癌研究的III期階段","url":"https://stock-news.laohu8.com/highlight/detail?id=2601078362","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601078362?lang=zh_tw&edition=fundamental","pubTime":"2026-01-05 08:09","pubTimestamp":1767571757,"startTime":"0","endTime":"0","summary":"智通财经APP讯,和黄医药 公布,公司今日宣布启动索凡替尼联合卡瑞利珠单抗、白蛋白结合型紫杉醇和吉西他滨用于一线治疗转移性胰腺导管腺癌患者的中国II/III期研究的III期部分。首名患者已于2025年12月30日接受首次给药治疗。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1388404.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4585","00013","BK4588","III","BK4134","BK1588","BK1587","HCM","BK4007","BK1191","BK4531"],"gpt_icon":1},{"id":"2595465795","title":"和黃醫藥(00013)宣佈賽沃替尼 (savolitinib) 用於治療伴有MET擴增的胃癌患者的中國新藥上市申請獲受理並獲納入優先審評","url":"https://stock-news.laohu8.com/highlight/detail?id=2595465795","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595465795?lang=zh_tw&edition=fundamental","pubTime":"2025-12-30 18:05","pubTimestamp":1767089147,"startTime":"0","endTime":"0","summary":"智通财经APP讯,和黄医药 公布,赛沃替尼用于经过至少2种治疗后失败的MET基因扩增的局部晚期或转移性胃癌或胃食道连接部腺癌成人患者的新药上市申请已获中国国家药品监督管理局受理,并获纳入优先审评。该新药上市申请是基于一项在中国开展的赛沃替尼用于治疗伴有MET扩增的胃癌患者的单臂、多中心、开放标签的II期注册研究的数据。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1387177.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["HCM","BK4585","LU1989772840.SGD","LU1989772923.USD","BK4162","00013","BK4588","BK1587","BK1588","LU1989771016.USD","MET","BK4007","LU1291159041.SGD","BK1191","BK4531","LU1496350502.SGD"],"gpt_icon":0},{"id":"2595788714","title":"和黃醫藥(00013)宣佈凡瑞格拉替尼 (HMPL-453) 用於二線治療肝內膽管癌的中國新藥上市申請獲受理並獲納入優先審評","url":"https://stock-news.laohu8.com/highlight/detail?id=2595788714","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2595788714?lang=zh_tw&edition=fundamental","pubTime":"2025-12-29 16:36","pubTimestamp":1766997386,"startTime":"0","endTime":"0","summary":"智通财经APP讯,和黄医药 发布公告,凡瑞格拉替尼 用于既往接受过系统性治疗,且具有成纤维细胞生长因子受体2融合或重排的晚期、转移性或不可手术切除的肝内胆管癌成人患者的新药上市申请已获中国国家药品监督管理局受理 ,并获纳入优先审评。凡瑞格拉替尼是一种新型、选择性的FGFR1 、2和3口服抑制剂。近年来,肝内胆管癌发病率呈持续上升趋势,5年总生存率约9%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1386500.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"和黄医药(00013)宣布凡瑞格拉替尼 (HMPL-453) 用于二线治疗肝内胆管癌的中国新药上市申请获受理并获纳入优先审评","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1588","00013","BK1587","HCM","BK4585","BK4588","BK1191","BK4531","BK4007"],"gpt_icon":0},{"id":"2593024851","title":"國家藥監局批准阿夫凱泰片上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2593024851","media":"新京报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593024851?lang=zh_tw&edition=fundamental","pubTime":"2025-12-22 15:41","pubTimestamp":1766389260,"startTime":"0","endTime":"0","summary":"新京报贝壳财经讯 12月22日,近日,国家药品监督管理局通过优先审评审批程序,批准Cytokinetics,Incorporated申报的1类创新药阿夫凯泰片(商品名:星舒平)上市,该药用于治疗纽约心脏协会(NYHA)心功能分级II-III级的梗阻性肥厚型心肌病(HCM)成人患者,以改善运动能力和症状。该药品上市为患者提供了新的治疗选择。","market":"hk","thumbnail":"https://media.bjnews.com.cn/cover/2025/12/04/5660775925944492210.jpeg?x-oss-process=image/resize,m_lfit,w_365","type":0,"news_type":0,"thumbnails":["https://media.bjnews.com.cn/cover/2025/12/04/5660775925944492210.jpeg?x-oss-process=image/resize,m_lfit,w_365"],"rights":{"source":"highlight_bjnews","url":"https://www.bjnews.com.cn/detail/1766388465129356.html","rn_cache_url":null,"customStyle":"handleCustomStyle(customStyle, ThemeStyle, getFont(fontSize))","selectors":"#main .nleft","filters":".ntit, .attitude","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.bjnews.com.cn/detail/1766388465129356.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_bjnews","symbols":["BK4588","BK4531","HCM","BK4007","BK4585"],"gpt_icon":0},{"id":"2592643199","title":"賽諾菲:第二代心肌肌球蛋白抑制劑星舒平在華獲批 實現「全球首發」","url":"https://stock-news.laohu8.com/highlight/detail?id=2592643199","media":"中国网财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592643199?lang=zh_tw&edition=fundamental","pubTime":"2025-12-17 15:01","pubTimestamp":1765954917,"startTime":"0","endTime":"0","summary":"中国网财经12月17日讯赛诺菲今日宣布,第二代心肌肌球蛋白抑制剂(CMI)星舒平(阿夫凯泰片)正式获得国家药监局(NMPA)批准,用于治疗纽约心脏协会(NYHA)心功能分级II-III级的梗阻性肥厚型心肌病(HCM)成人患者,以改善运动能力和症状。阿夫凯泰片是肥厚型心肌病领域潜在“同类最佳”的治疗药物。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202512173594183219.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202512173594183219.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK4149","LU0154245673.USD","BK4567","LU0203345920.USD","LU0203347892.USD","LU0154245756.USD","BK4585","CMI","HCM","BK4588","BK4533","BK4531","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":1,"totalSize":71,"code":"91000000","status":"200"}]}}